OneChain Immunotherapeutics

OneChain Immunotherapeutics

Biotechnology Research

Development of CAR-T candidates for the treatment of acute lymphoblastic leukemia and other hematological malignancies.

About us

OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.

Industry
Biotechnology Research
Company size
2-10 employees
Type
Privately Held
Founded
2020
Specialties
Biomedicina, CARTs, Inmunoterapia, Investigación, Biotecnología, Innovación, Leucemia, Hematología, and Medicina Personalizada

Employees at OneChain Immunotherapeutics

Updates

Similar pages

Browse jobs

Funding